Skip to content

Study & NCLEX

Diuretic Drugs: Nursing Pharmacology Study Guide

Medically reviewed by Jonathan Kim, DO

Last reviewed Jun 11, 2026·Next review Jun 11, 2027

· 11 min read

Diuretics: Generic and Brand Names

  • Thiazide Diuretics
    • bendroflumethiazide (Naturetin)
    • chlorothiazide (Diuril)
    • hydrochlorothiazide (HydroDIURIL)
    • hydroflumethiazide (Saluron)
    • methyclothiazide (Enduron)
  • Thiazide-like Diuretics
    • chlorthalidone (Hygroton)
    • indapamide (Lozol)
    • metolazone (Mykrox, Zaroxolyn)
  • Loop Diuretics
    • bumetanide (Bumex)
    • ethacrynic acid (Edecrin)
    • furosemide (Lasix)
    • torsemide (Demadex)
  • Carbonic Anhydrase Inhibitors
    • acetazolamide (Diamox)
    • methazolamide (Glauctabs)
  • Potassium-sparing Diuretics
    • amiloride (Midamor)
    • spironolactone (Aldactone)
    • triamterene (Dyrenium)
  • Osmotic Diuretics
    • mannitol (Osmitrol)

Disease Spotlight: Edema, Hypertension, and Glaucoma

Edema is fluid pooling in the interstitial spaces, classically in heart failure (HF), cirrhosis and other liver disease, and renal disease. In HF, inefficient pumping activates the renin-angiotensin system, so blood volume rises and sodium is retained. In liver disease, edema comes from two directions: reduced plasma protein production lowers oncotic pressure (the pressure that holds fluid in), and portal obstruction from hepatic vessel congestion backs fluid up. In renal disease, a damaged basement membrane lets plasma proteins spill into the urine.

Hypertension is persistent higher-than-normal blood pressure, mostly idiopathic. Left untreated, it drives multiple organ failure and severe cardiovascular complications. Diuretics lower it by cutting circulating fluid volume and sodium.

Glaucoma is increased intraocular pressure (IOP). Untreated, high IOP damages the optic nerve and causes irreversible blindness. Diuretics help by boosting the osmotic pull that draws fluid out of the eye, dropping IOP.

Thiazide and Thiazide-like Diuretics

Thiazide diuretics belong to the sulfonamide class. Thiazide-like diuretics have a different structure but the same mechanism. This is one of the most commonly used diuretic classes.

Therapeutic action. They block the chloride pump in the ascending limb of the loop of Henle and the distal tubule, actively pumping chloride out of the lining cells. Sodium follows chloride to maintain electrical neutrality, so both are excreted in the urine.

Indications. A milder diuretic than the loop agents, and a first-line drug for essential hypertension. In children, established pediatric dosing treats edema from heart defects and hepatorenal disease and controls hypertension; because children metabolize rapidly, the effect can be abrupt, so monitor serum electrolytes and fluid volume closely.

Contraindications and cautions:

  • Allergy to thiazides and sulfonamides. Prevents severe hypersensitivity reactions.
  • Fluid and electrolyte imbalances. Potentiated by the fluid and electrolyte changes diuretics cause.
  • Severe renal failure, anuria. May stop the drug from working and can precipitate a crisis from altered blood flow.
  • Systemic lupus erythematosus (SLE). Can precipitate renal failure, since the disease already changes glomerular filtration.
  • Glucose tolerance abnormalities and diabetes mellitus. Worsened by the glucose-elevating effect of some diuretics.
  • Gout. Already reflects abnormal tubular reabsorption and secretion.
  • Liver disease. Can interfere with metabolism and lead to toxicity.
  • Bipolar disorder. Can be exacerbated by calcium changes from the drug.
  • Pregnancy, lactation. Potential adverse effects on the fetus and infant. Routine use in pregnancy is inappropriate; reserve it for underlying pathology. Lactating women should switch feeding methods.

Adverse effects. Weakness; hypotension and arrhythmias; GI upset; hypokalemia (can precipitate hyperglycemia), hypercalcemia, hyperuricemia, and slightly alkalinized urine (can lead to bladder infections).

Thiazide-type diuretics remain a first-line option for primary hypertension. The 2025 ACC/AHA hypertension guideline gives them a Class I, Level A recommendation alongside calcium channel blockers, ACE inhibitors, and ARBs as initial therapy for most adults (StatPearls, Thiazide Diuretics).

Interactions. Cholestyramine or colestipol decrease diuretic absorption, so separate doses by at least 2 hours. Digoxin raises the risk of digoxin toxicity through serum potassium shifts. Quinidine raises the risk of quinidine toxicity. Antidiabetic agents lose effectiveness. Lithium raises the risk of lithium toxicity.

Loop Diuretics

Loop diuretics act mainly on the loop of Henle, which is where the name comes from. They are called high-ceiling diuretics because they produce far greater diuresis than the other classes.

Therapeutic action. They block the chloride pump in the ascending limb of the loop of Henle, where 30% of sodium is normally reabsorbed, cutting chloride and sodium reabsorption. The same effect on the descending limb and distal tubule produces sodium-rich urine.

Indications. Used for acute HF, acute pulmonary edema, edema from HF or renal or liver disease, and hypertension. This is the drug of choice when rapid, extensive diuresis is needed; it can produce a fluid loss up to 20 pounds per day. It works even with acid-base disturbances, renal failure, electrolyte imbalances, and nitrogen retention. Ethacrynic acid is used less often now that newer drugs are more potent and reliable. In children, furosemide is used when a stronger diuretic is needed, but the dose should not exceed 6 mg/kg/d; ethacrynic acid is given orally in some cases but not in infants; bumetanide is generally not recommended for children but is indicated when the child takes other ototoxic drugs (such as antibiotics), since it causes less hypokalemia, which makes it a good fit for children also taking digoxin.

Contraindications and cautions:

  • Allergy to loop diuretics and sulfonamides. Prevents severe hypersensitivity reactions.
  • Electrolyte depletion. Potentiated by the fluid and electrolyte changes diuretics cause.
  • Severe renal failure, anuria. Exacerbated by the drug.
  • Systemic lupus erythematosus (SLE). Can precipitate renal failure.
  • Glucose tolerance abnormalities and diabetes mellitus. Worsened by the glucose-elevating effect.
  • Gout. Already reflects abnormal tubular reabsorption and secretion.
  • Hepatic coma. Exacerbated by drug-related fluid shifts.
  • Pregnancy, lactation. Potential adverse effects on the fetus and infant. Routine use in pregnancy is inappropriate; reserve it for underlying pathology. Lactating women should switch feeding methods.

Adverse effects. Dizziness; hypotension; GI upset; hypokalemia (can precipitate hyperglycemia), increased bicarbonate excretion (can lead to alkalosis), hypocalcemia and tetany; ototoxicity with reversible hearing loss.

Interactions. Aminoglycosides or cisplatin increase ototoxicity. Anticoagulants gain increased anticoagulation effect. Indomethacin, ibuprofen, salicylates, and other NSAIDs decrease the antihypertensive effect and cause sodium loss.

Carbonic Anhydrase Inhibitors

Relatively mild diuretics.

Therapeutic action. They inhibit carbonic anhydrase, the enzyme that forms the sodium bicarbonate stored as alkaline reserve in the renal tubules and needed to excrete hydrogen. Slowing hydrogen ion movement means more sodium and bicarbonate are lost in the urine.

Indications. Most often for glaucoma, where inhibiting carbonic anhydrase decreases secretion of aqueous humor; also as an adjunct to other diuretics when more intense diuresis is needed. Not indicated for children.

Contraindications and cautions:

  • Allergy to carbonic anhydrase inhibitors, thiazides, antibacterial sulfonamides. Prevents severe hypersensitivity reactions.
  • Chronic noncongestive angle-closure glaucoma. Not effectively treated by this drug.
  • Fluid and electrolyte imbalance, renal or hepatic disease, adrenocortical insufficiency, respiratory acidosis, COPD. Exacerbated by the fluid and electrolyte changes.
  • Pregnancy, lactation. Potential adverse effects on the fetus and infant. Routine use in pregnancy is inappropriate; reserve it for underlying pathology. Lactating women should switch feeding methods.

Adverse effects. Paresthesia, confusion, drowsiness; hypotension; hypokalemia (can precipitate hyperglycemia), increased bicarbonate loss (can lead to metabolic acidosis).

Interactions. Salicylate and lithium show increased excretion.

Potassium-Sparing Diuretics

Less powerful than loop diuretics, but they hold onto potassium instead of wasting it. Used mainly for patients at high risk for hypokalemia from diuretic use.

Therapeutic action. They lose sodium while retaining potassium. Spironolactone is an aldosterone antagonist that blocks aldosterone in the distal tubule; amiloride and triamterene block potassium secretion through the tubule.

Indications. Often an adjunct to thiazide or loop diuretics, or for patients at risk if hypokalemia develops. Spironolactone is the drug of choice for hyperaldosteronism, typically seen in liver cirrhosis and nephrotic syndrome. In children, spironolactone is the only potassium-sparing diuretic recommended.

Contraindications and cautions:

  • Allergy to potassium-sparing diuretics. Prevents severe hypersensitivity reactions.
  • Hyperkalemia, renal disease, anuria. Exacerbated by the drug.
  • Pregnancy, lactation. Potential adverse effects on the fetus and infant. Routine use in pregnancy is inappropriate; reserve it for underlying pathology. Lactating women should switch feeding methods.

Adverse effects. Lethargy, confusion, ataxia; arrhythmias; muscle cramps; hyperkalemia, increased bicarbonate loss (can lead to metabolic acidosis); androgen effects such as hirsutism, gynecomastia, deepening of the voice, and irregular menses. Counsel adults to avoid potassium-rich foods (avocados, bananas, broccoli, tomatoes, dried fruits) and to have regular serum potassium checks.

Interactions. Salicylates decrease the diuretic effect.

Osmotic Diuretics

These pull water into the renal tubule without losing sodium. Only one is currently available: mannitol (Osmitrol).

Therapeutic action. Mannitol is a sugar the tubules barely reabsorb, so it drags large amounts of fluid into the urine by osmotic pull. It also pulls fluid into the vascular system from extravascular spaces such as the aqueous humor.

Indications. Used acutely to decrease IOP before eye surgery or during acute glaucoma attacks; the diuretic of choice for increased cranial pressure or acute renal failure from shock, drug overdose, or trauma; also an irrigant in transurethral prostatic resection and other transurethral procedures. Not indicated for children.

Contraindications and cautions:

  • Renal disease, anuria, pulmonary congestion, intracranial bleeding, dehydration, HF. Exacerbated by the large fluid shifts the drug causes.
  • Pregnancy, lactation. Potential adverse effects on the fetus and infant. Routine use in pregnancy is inappropriate; reserve it for underlying pathology. Lactating women should switch feeding methods.

Adverse effects. Light-headedness, confusion, headache; hypotension, cardiac decompensation, shock; nausea, vomiting; fluid and electrolyte imbalance. The most common and dangerous effect is a sudden drop in fluid levels.

Pharmacokinetics

Thiazide and Thiazide-like Diuretics

RouteOnsetPeakDuration
Oral2 h4-6 h6-12 h
Half-life (T1/2)MetabolismExcretion
5.6-14 hliverkidney (urine)

Loop Diuretics

RouteOnsetPeakDuration
Oral60 min60-120 min6-8 h
IV, IM5 min30 min2 h
Half-life (T1/2)MetabolismExcretion
120 minliverkidney (urine)

Carbonic Anhydrase Inhibitors

RouteOnsetPeakDuration
Oral1 h2-4 h6-12 h
Sustained-release oral2 h8-12 h18-24 h
IV1-2 min15-18 min4-5 h
Half-life (T1/2)MetabolismExcretion
5-6 hN/Aurine (unchanged)

Potassium-Sparing Diuretics

RouteOnsetPeakDuration
Oral24-48 h48-72 h48-72 h
Half-life (T1/2)MetabolismExcretion
20 hliverurine (unchanged)

Osmotic Diuretics

RouteOnsetPeakDuration
IV30-60 min1 h6-8 h
IrrigantRapidRapidShort
Half-life (T1/2)MetabolismExcretion
15-100 minN/Aurine (unchanged)

Diuretics Across Age Groups

Adults are more likely to be on diuretics long-term. Teach them the warning signs of fluid volume change that need prompt attention, have them weigh themselves daily, and flag conditions that aggravate fluid loss (vomiting, diarrhea, profuse sweating) that may change the dose. In pregnancy, do not use diuretics to influence fluid shifts; if one is already indicated for a specific medical cause, do not stop it, but make the patient aware of possible fetal effects. Lactating women should switch to an alternative feeding method. In older adults, renal and hepatic impairment is common, so start at the lowest possible dose, titrate slowly to response, and monitor serum electrolytes, activity level, and dietary intake closely.

Nursing Considerations for Diuretic Drugs

Nursing Assessment

Screen for the cautions and contraindications above (drug allergies, fluid and electrolyte disturbances, hepatorenal disease, glucose tolerance abnormalities). Do a thorough baseline physical assessment. Inspect the skin for edema and turgor to gauge hydration. Assess cardiopulmonary status (blood pressure, pulse, heart and lung sounds) for fluid movement and cardiac and pulmonary effects. Get an accurate body weight as a fluid-balance baseline. Monitor intake, output, and voiding patterns. Evaluate liver status for metabolism problems. Track lab results, especially serum potassium and calcium, uric acid, and glucose, plus liver and renal function tests, to catch the need for dose adjustment and toxic effects.

Nursing Diagnoses

  • Impaired urinary elimination related to drug effect
  • Imbalanced nutrition: less than body requirements related to GI upset and metabolic changes
  • Risk for deficient fluid volume related to increased fluid excretion
  • Risk for injury related to changes in fluid volume and electrolyte balance

Implementation with Rationale

Give the drug with food or milk if GI upset is a problem. Give IV diuretics slowly to prevent severe fluid and electrolyte shifts. Give the oral form early in the day so increased urination does not interrupt sleep. Monitor response through vital signs, weight, serum electrolytes, and hydration. Assess skin condition for fluid deficit or retention. Provide comfort measures (skin care, nutrition referral) and safety measures (adequate lighting, raised side rails). Educate the patient on the regimen to promote compliance.

Evaluation

Monitor the response to therapy (weight, urinary output, edema changes, blood pressure) and for adverse effects (electrolyte imbalance, hyperglycemia, hyperuricemia, acid-base disturbances). Confirm the patient can name the drug, its indication, and the adverse effects to watch for, and monitor compliance.

Frequently Asked Questions

Which labs matter most for a patient on a diuretic? Serum potassium leads the list. Loop and thiazide agents waste potassium, so you watch for hypokalemia; potassium-sparing agents do the opposite and can drive hyperkalemia. Also track sodium, calcium, uric acid, glucose, and renal function, plus a daily weight.

Which diuretics protect potassium instead of wasting it? Spironolactone, amiloride, and triamterene. Spironolactone blocks aldosterone in the distal tubule; amiloride and triamterene block potassium secretion directly. They are weaker than loop agents and are often paired with a thiazide or loop diuretic to offset potassium loss.

Why give an oral diuretic in the morning? The drug increases urination for several hours after a dose, so a morning schedule keeps the patient from being up all night and supports compliance.

Are thiazides still first-line for high blood pressure? Yes. The 2025 ACC/AHA hypertension guideline keeps thiazide-type diuretics as a Class I, Level A first-line option for most adults with primary hypertension, alongside calcium channel blockers, ACE inhibitors, and ARBs.

What is the most dangerous effect of a loop diuretic? Rapid, large fluid and electrolyte loss. Loop agents are high-ceiling diuretics that can pull off a lot of volume fast, which risks hypotension, hypokalemia, and dehydration. Given IV too quickly they can also cause ototoxicity and reversible hearing loss.

Sources

Primary references for the figures and claims on this page. Verify any clinical value against the source before you act on it.